genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Hepatitis B
GEN Edge
StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
Coronavirus
And Then There Were Four: VBI Scores First FDA Approval with Hepatitis B Vaccine
Cancer
NIH Blood Test Developed for Liver Cancer Screening
News
University of Queensland (UQ), CEPI, CSL Behring and Dynavax – UQ-CSL V451
GEN Edge
Roche, Dicerna Launch Up-to-$1.67B Hepatitis B Collaboration
Infectious Diseases
$20 Blood Test Could Contribute to “Global HBV Elimination”
New Products
Hepatitis B Monoclonal Antibodies
Insights
RNAi Therapeutics: To the Liver … and Beyond
Drug Discovery
Hepatitis B Infects Organ-on-a-Chip Platform
Insights
The Prodrug Opportunity: Making Good Drugs Better
1
2
3
...
6
Page 1 of 6
Scroll Up
Scroll Up
